|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 | |||
| A61K 35/17 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3384052 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16871163.8 |
| Europos patento paraiškos padavimo data | 2016-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SG2016/050441 |
| Data | 2016-09-09 |
| (87) | Numeris | WO 2017/095324 |
| Data | 2017-06-08 |
| (30) | Numeris | Data | Šalis |
| 10201509979S | 2015-12-04 | SG |
| (72) |
CONNOLLY, John, SG
HOPKINS, Richard, SG
TOH, Han Chong, SG
|
| (73) |
Agency for Science, Technology and Research,
1 Fusionopolis Way 20-10, Connexis North Tower, Singapore 138632,
SG
Tessa Therapeutics Ltd., 8 Temasek Boulevard No.24-02, Suntec Tower Three, Singapore 038988, SG Singapore Health Services Pte. Ltd., 31 Third Hospital Avenue No.03-03 Bowyer Block C, Singapore 168753, SG |
| (54) | CLINICAL CORRELATES OF IMMUNOTHERAPY EFFICACY |
| CLINICAL CORRELATES OF IMMUNOTHERAPY EFFICACY |